Evidence map›Paper›PMID 21750608›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2011

Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery.

Rahul Reddy, Stephen Jae Kim

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Optimization of structures, biochemical properties of ketorolac and its degradation products based on computational studies.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2019
    Article
  8. Principles of pharmacology in the eye.British journal of pharmacology · 2017
    Review
  9. The safety, pharmacokinetics, and efficacy of intraocular celecoxib.Investigative ophthalmology & visual science · 2014
    Article
  10. Article
  11. Article
  12. Nonsteroidal anti-inflammatory drugs for retinal disease.International journal of inflammation · 2013
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rahul ReddyDepartment of Ophthalmology, Vanderbilt University, Nashville, TN, USA.
Stephen Jae Kim
Vanderbilt Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe purpose of this review was to provide a critical appraisal of the literature supporting the efficacy of ophthalmic ketorolac (Acuvail(®)) in the treatment of pain and inflammation after cataract surgery.

methodsLiterature search and expert opinion of the authors.

resultsRecent studies indicate greater intraocular drug levels in the anterior chamber and iris-ciliary body after topical application of Acuvail in comparison with older formulations of ketorolac. A large randomized, multicenter, placebo-controlled study demonstrated significantly less inflammation and pain after cataract surgery using Acuvail.

conclusionAcuvail appears to be effective in reducing post-cataract surgery pain and inflammation.

Indexed as

Acuvail®cystoid macular edemaketorolac tromethaminenonsteroidal anti-inflammatory drugspostsurgical

Identifiers

PMID21750608
PMCPMC3130912
OpenAlexW1971332590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.